Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • RegenxBio proposes IPO

    RegenxBio Inc., Washington, D.C. Business: Gene/Cell therapy Date announced: 2015-08-17 Type: IPO To be raised: Up to $100 million Shares: TBD Price: TBD Underwriters: Morgan Stanley; BofA Merrill Lynch; Piper Jaffray; …

    Published on 8/24/2015
  • WaferGen proposes private placement of units

    WaferGen Bio-systems Inc. (NASDAQ:WGBS), Fremont, Calif. Business: Supply/Service Date announced: 2015-08-14 Type: Private placement of units To be raised: Up to $34.5 million Units: TBD Price Prior: $1.31 Shares …

    Published on 8/24/2015
  • Benitec amends follow-on

    Benitec Biopharma Ltd. (ASX:BLT), Sydney, Australia Business: Functional genomics, Proteomics Date announced: 2015-08-13 Type: Follow-on To be raised: Up to $17.3 million Shares: 1.5 million Price Prior: A$0.78 …

    Published on 8/17/2015
  • Exagen amends IPO

    Exagen Diagnostics Inc., Albuquerque, N.M. Business: Diagnostic Date announced: 2015-08-12 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Leerink Partners; Baird; William Blair Note: Exagen amended its…

    Published on 8/17/2015
  • GenSight Biologics amends IPO

    GenSight Biologics S.A., Paris, France Business: Ophthalmic Date announced: 2015-08-10 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Leerink Partners; Evercore; Canaccord Note: GenSight amended its …

    Published on 8/17/2015
  • Achaogen completes debt financing

    Achaogen Inc. (NASDAQ:AKAO), South San Francisco, Calif. Business: Infectious Date completed: 2015-08-05 Type: Debt financing Raised: $15 million Shares outstanding prior: 18.1 million Investor: Solar Capital Ltd. Note:…

    Published on 8/17/2015
  • Alligator Bioscience completes venture financing

    Alligator Bioscience AB, Lund, Sweden Business: Antibodies, Cancer Date completed: 2015-08-12 Type: Venture financing Raised: Not disclosed Investor: Johnson & Johnson Development Corp. Note: The amount raised is not …

    Published on 8/17/2015
  • AMAG Pharmaceuticals completes private placement of senior notes

    AMAG Pharmaceuticals Inc. (NASDAQ:AMAG), Lexington, Mass. Business: Hematology Date completed: 2015-08-12 Type: Private placement of senior notes Raised: $500 million Shares outstanding prior: 34.5 million Investor: …

    Published on 8/17/2015
  • Ascentage completes venture financing

    Ascentage Pharma Group Corp. Ltd., Hong Kong, China Business: Cancer Date completed: 2015-08-08 Type: Venture financing Raised: $15.5 million Investors: Oriza Capital; YuanMing Capital; EFung Capital; BioVenture Capital…

    Published on 8/17/2015
  • Biohaven completes venture financing

    Biohaven Pharmaceutical Holding Co. Ltd., Tortola, Virgin Islands Business: Neurology Date completed: 2015-08-11 Type: Venture financing Raised: $4.1 million Investors: Portage Biotech; and other undisclosed investors

    Published on 8/17/2015
  • Checkmate Pharma completes venture financing

    Checkmate Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Date completed: 2015-08-12 Type: Venture financing Raised: $20 million Investors: Sofinnova Ventures; venBio LLC

    Published on 8/17/2015
  • Editas Medicine completes venture financing

    Editas Medicine, Cambridge, Mass. Business: Gene/Cell therapy, Genomics Date completed: 2015-08-10 Type: Venture financing Raised: $120 million

    Published on 8/17/2015
  • Emerge Resources completes private placement of units

    Emerge Resources Corp. (TSX-V:EME), Vancouver, B.C. Business: Other Date completed: 2015-08-13 Type: Private placement of units Raised: C$2.7 million ($2 million) Units: 23.2 million Price: C$.12 Shares after offering: …

    Published on 8/17/2015
  • Global Blood Therapeutics completes IPO

    Global Blood Therapeutics Inc. (NASDAQ:GBT), South San Francisco, Calif. Business: Hematology Date completed: 2015-08-11 Type: IPO Raised: $120 million Shares: 6 million Price: $20 Shares after offering: 27.8 million …

    Published on 8/17/2015
  • Inotek completes follow-on

    Inotek Pharmaceuticals Corp. (NASDAQ:ITEK), Lexington, Mass. Business: Ophthalmic, Renal, Autoimmune Date completed: 2015-08-13 Type: Follow-on Raised: $68.9 million Shares: 5.4 million Price: $12.75 Shares after …

    Published on 8/17/2015
  • Ovid Therapeutics completes venture financing

    Ovid Therapeutics Inc., New York, N.Y. Business: Neurology, Endocrine/Metabolic Date completed: 2015-08-11 Type: Venture financing Raised: $75 million Placement agent: Cowen Investors: Fidelity; Cowen Private …

    Published on 8/17/2015
  • PTC completes private placement of senior convertible notes

    PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Musculoskeletal, Pulmonary, Neurology Date completed: 2015-08-11 Type: Private placement of senior convertible notes Raised: $125 million Shares …

    Published on 8/17/2015
  • Rhythm Holding completes venture financing

    Rhythm Holding Co. LLC, Boston, Mass. Business: Endocrine/Metabolic, Gastrointestinal Date completed: 2015-08-13 Type: Venture financing Raised: $40 million Investors: OrbiMed Advisors; Deerfield Management; Wellington …

    Published on 8/17/2015
  • Sentien Biotechnologies completes venture financing

    Sentien Biotechnologies Inc., Medford, Mass. Business: Renal Date completed: 2015-08-07 Type: Venture financing Raised: Not disclosed Investors: Boehringer Ingelheim Venture Fund; Portage Biotech Note: The amount raised…

    Published on 8/17/2015
  • Turing Pharmaceuticals completes venture financing

    Turing Pharmaceuticals AG, New York, N.Y. Business: Cardiovascular, Neurology Date completed: 2015-08-10 Type: Venture financing Raised: $90 million Investors: Company founder; institutional investors Note: Turing also …

    Published on 8/17/2015
  • Aimmune Therapeutics financial update

    Aimmune Therapeutics Inc. (NASDAQ:AIMT), Brisbane, Calif. Business: Inflammation Date announced: 2015-08-11 Note: Aimmune raised $24 million through the sale of 1.5 million shares at $16 to cover the overallotment from …

    Published on 8/17/2015
  • Cardiome financial update

    Cardiome Pharma Corp. (TSX:COM; NASDAQ:CRME), Vancouver, B.C. Business: Cardiovascular Date announced: 2015-08-13 Note: Cardiome raised $3 million through the sale of 375,000 shares at $8 to cover the overallotment from…

    Published on 8/17/2015
  • Dermira financial update

    Dermira Inc. (NASDAQ:DERM), Menlo Park, Calif. Business: Dermatology Date announced: 2015-08-11 Note: Dermira raised $14.5 million through the sale of 675,000 shares at $21.50 to cover the overallotment from its Aug. 5 …

    Published on 8/17/2015
  • Zynerba financial update

    Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE), Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Date announced: 2015-08-10 Note: Zynerba raised $6.3 million through the sale of 450,000 shares at $14 to cover the …

    Published on 8/17/2015
  • FortuneRock proposes IPO

    FortuneRock Co. Ltd., Beijing, China Business: Cancer, Inflammation, Infectious Date announced: 2015-07-30 Type: IPO To be raised: TBD Shares: TBD Price: TBD Overallotment: TBD Note: FortuneRock is seeking to list its …

    Published on 8/17/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993